Trifluoroacetic acid → N-(5-(4-acetylpiperazin-1-yl)pyridin-2-yl)-2-(3-cyano-4-(2-fluoropyridin-4-yl)phenyl)acetamide

HRID 1036282ノート

反応式

HRID 1036282 の反応式
[C:1]([C:3]1[CH:4]=[C:5]([CH2:16][C:17]([O:19]C(C)(C)C)=O)[CH:6]=[CH:7][C:8]=1[C:9]1[CH:14]=[CH:13][N:12]=[C:11]([F:15])[CH:10]=1)#[N:2].[C:24](O)([C:26](F)(F)F)=[O:25].N1C=CN=CC=1[C:37]1[CH:38]=[CH:39][C:40]([NH2:43])=[N:41][CH:42]=1.CCN(C(C)C)C(C)C.F[P-](F)(F)(F)(F)F.N1(OC(N(C)C)=[N+](C)C)[C:64]2[N:65]=[CH:66][CH:67]=C[C:63]=2[N:62]=N1>C(Cl)Cl>[C:24]([N:62]1[CH2:63][CH2:64][N:65]([C:37]2[CH:38]=[CH:39][C:40]([NH:43][C:17](=[O:19])[CH2:16][C:5]3[CH:6]=[CH:7][C:8]([C:9]4[CH:14]=[CH:13][N:12]=[C:11]([F:15])[CH:10]=4)=[C:3]([C:1]#[N:2])[CH:4]=3)=[N:41][CH:42]=2)[CH2:66][CH2:67]1)(=[O:25])[CH3:26]

参加物

7

実験手順

A mixture of tert-butyl 2-(3-cyano-4-(2-fluoropyridin-4-yl)phenyl)acetate 206-5 (35 mg, 0.11 mmol) and TFA (0.5 mL) in DCM (3 mL) was stirred at room temperature for 5 hours. The solvents were evaporated to dryness under high vacuum. The crude product, 2-(3-cyano-4-(2-fluoropyridin-4-yl)phenyl)acetic acid 206-6, was dissolved in DMF (2 mL). 5-(pyrazin-2-yl)pyridin-2-amine (23 mg, 0.13 mmol) and DIEA (98 uL, 0.56 mmol) were added to the solution before O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluroniumhexafluorophosphate (64 mg, 0.17 mmol). The mixture was stirred at room temperature overnight. The mixture was stirred at room temperature overnight. The solvent was removed by rotary evaporation. The crude product was purified by reverse phase HPLC to give N-(5-(4-acetylpiperazin-1-yl)pyridin-2-yl)-2-(3-cyano-4-(2-fluoropyridin-4-yl)phenyl)acetamide 206. MS m/z 411.2 (M+1); 1H NMR 400 MHz (MeOD) δ 9.09 (s, 1H), 9.01 (s, 1H), 8.66 (dd, 1H), 8.52 (d, 1H), 8.42 (dd, 1H), 8.32 (d, 1H), 8.25 (d, 1H), 7.92 (d, 1H), 7.81 (dd, 1H), 7.64 (d, 1H), 7.52 (dt, 1H), 7.28 (s, 1H), 3.93 (s, 2H).

後処理

  1. customThe solvents were evaporated to dryness under high vacuum
  2. dissolutionThe crude product, 2-(3-cyano-4-(2-fluoropyridin-4-yl)phenyl)acetic acid 206-6, was dissolved in DMF (2 mL)
  3. stirringThe mixture was stirred at room temperature overnight
  4. stirringThe mixture was stirred at room temperature overnight
  5. customThe solvent was removed by rotary evaporation
  6. customThe crude product was purified by reverse phase HPLC

出典と根拠

ORDレコード
ord-31dbcf255b05441e83e697cb02331c6c
出典データセット
uspto-grants-2013_10
特許番号
US08546396B2

反応ノート

読み込み中…